glp 1 pathophysiology Glucagon-like peptide in health and disease Frontiers | Dissecting the Physiology
Description
Trmper A, Trmper K, Trusheim H, Arnold R, Gke B, Hrsch D
doi: 10.1152/jappl.1957.11.3.419 63 GearyNSmithGP
Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications originally developed for type 2 diabetes management and, more recently, approved for weight management
Media and Third-Party Validation Perfect No as seen on logos or testing claims that needed primary-source verification
